|
|
Bristol-Myers Squibb Co.
|
 |
||||||||
|
 |
  |
 |
|
|
||
 |
 |
 
|
return to message board, top of board |
Amgen's Otezla Revenue Split by US versus Rest of World (ROW)Sotyktu has been approved in Japan and earlier this week EU. Reimbursement in EU is country-by-country and typically takes 12-18 months to complete post-approval. This excerpt is from AMGN's 2022 10-K:  |
|
|
return to message board, top of board |
| Msg # | Subject | Author | Recs | Date Posted |
| 11005 | Re: Amgen's Otezla Revenue Split by US versus Rest of World (ROW) | Baltasar | 1 | 3/31/2023 10:00:27 AM |
